Shedir Pharma

Shedir Pharma Group is an Italian pharmaceutical company specializing in the research, development, and marketing of nutraceuticals, medical devices, and dermo-cosmetic products. Founded in 2008 and headquartered in Piano di Sorrento, the company operates through a multi-brand strategy with key divisions including Shedir Pharma, Deimos, and Dymalife. The group is listed on the Euronext Growth Milan exchange and maintains a significant presence in the Italian market through an extensive network of scientific sales representatives. Their portfolio covers a wide range of therapeutic areas such as cardiology, respiratory health, and neurology, with a strong emphasis on patented and clinically-validated formulations. Shedir Pharma's business model focuses on high-margin health products that bridge the gap between traditional pharmaceuticals and dietary supplements.